ImageneBio, Inc. (IMA)

ImageneBio Statistics

Total Valuation

ImageneBio has a market cap or net worth of $80.95 million. The enterprise value is -$56.81 million.

Market Cap	80.95M
Enterprise Value	-56.81M

Important Dates

The last earnings date was Wednesday, November 12, 2025, before market open.

Earnings Date	Nov 12, 2025
Ex-Dividend Date	n/a

Share Statistics

ImageneBio has 10.65 million shares outstanding. The number of shares has increased by 22.60% in one year.

Current Share Class	10.65M
Shares Outstanding	10.65M
Shares Change (YoY)	+22.60%
Shares Change (QoQ)	-98.16%
Owned by Insiders (%)	1.49%
Owned by Institutions (%)	21.66%
Float	6.33M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	102.91
Forward PS	n/a
PB Ratio	0.59
P/TBV Ratio	0.59
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 13.24, with a Debt / Equity ratio of 0.02.

Current Ratio	13.24
Quick Ratio	12.86
Debt / Equity	0.02
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-112.69

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	n/a
Return on Invested Capital (ROIC)	n/a
Return on Capital Employed (ROCE)	-30.78%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	-61,000
Effective Tax Rate	n/a

Stock Price Statistics

Beta (5Y)	n/a
52-Week Price Change	n/a
50-Day Moving Average	8.19
200-Day Moving Average	n/a
Relative Strength Index (RSI)	37.63
Average Volume (20 Days)	70,458

Short Selling Information

The latest short interest is 366,955, so 3.45% of the outstanding shares have been sold short.

Short Interest	366,955
Short Previous Month	104,875
Short % of Shares Out	3.45%
Short % of Float	5.80%
Short Ratio (days to cover)	1.31

Income Statement

In the last 12 months, ImageneBio had revenue of $800,000 and -$53.36 million in losses. Loss per share was -$0.14.

Revenue	800,000
Gross Profit	800,000
Operating Income	-46.09M
Pretax Income	-43.31M
Net Income	-53.36M
EBITDA	-46.07M
EBIT	-46.09M
Loss Per Share	-$0.14

Balance Sheet

The company has $142.58 million in cash and $3.45 million in debt, giving a net cash position of $139.14 million or $13.06 per share.

Cash & Cash Equivalents	142.58M
Total Debt	3.45M
Net Cash	139.14M
Net Cash Per Share	$13.06
Equity (Book Value)	139.83M
Book Value Per Share	13.13
Working Capital	136.39M

Cash Flow

Operating Cash Flow	-44.10M
Capital Expenditures	n/a
Free Cash Flow	-44.10M
FCF Per Share	-$4.14

Margins

Gross Margin	100.00%
Operating Margin	-5,761.13%
Pretax Margin	-5,414.25%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

ImageneBio does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-22.60%
Shareholder Yield	-22.60%
Earnings Yield	-64.81%
FCF Yield	-53.56%

Analyst Forecast

The average price target for ImageneBio is $30.00, which is 294.74% higher than the current price. The consensus rating is "Buy".

Price Target	$30.00
Price Target Difference	294.74%
Analyst Consensus	Buy
Analyst Count	1
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	113.35%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

ImageneBio has an Altman Z-Score of 2.01 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.01
Piotroski F-Score	2